Castelo-Branco, LPires Silva, ICanhão, HAwada, A2019-05-162019-05-162019-04-30Acta Med Port. 2019 Apr 30;32(4):251-257.http://hdl.handle.net/10400.17/3251engCHLC REUMAntibodies, Monoclonal/therapeutic useCTLA-4 Antigen/antagonists & inhibitorsCancer Vaccines/therapeutic useImmunotherapy, Adoptive/methodsLymphocyte ActivationMelanoma/therapyNeoplasms/therapyNobel PrizeProgrammed Cell Death 1 Receptor/antagonists & inhibitorsSkin Neoplasms/therapyPromising Immuno-Oncology Treatments Beyond the 2018 Nobel PrizeTratamentos Promissores de Imuno-Oncologia Para Além do Prémio Nobel 2018journal article10.20344/amp.12040